UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Revista de filosofía (México), 2020-12, Vol.53 (150), p.44-72

2020

Volltextzugriff (PDF)

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Cancer letters, 2017-12, Vol.411, p.35-43

2017

Volltextzugriff (PDF)

Dating the late Miocene marine sediments around the southern middle Durance valley (Provence, SE France): new evidences for a Tortonian age

Bulletin de la Société géologique de France, 2024-01, Vol.195, p.14

2024

Volltextzugriff (PDF)

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.E1465-E1473

2013

Volltextzugriff (PDF)

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Clinical cancer research, 2009-08, Vol.15 (15), p.4954-4962

2009

Volltextzugriff (PDF)

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.833-IN11

2012

Volltextzugriff (PDF)

Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1816-1818

2007

Volltextzugriff (PDF)

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Neoplasia (New York, N.Y.), 2011-03, Vol.13 (3), p.217-IN3

2011

Volltextzugriff (PDF)

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Pharmacogenomics, 2012-07, Vol.13 (9), p.1037-1053

2012

Volltextzugriff (PDF)

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Revista de filosofía (México), 2021, Vol.53 (150), p.44-72

Alison Assiter, Anna Fioravanti

2021

Volltextzugriff (PDF)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

TheScientificWorld, 2012-01, Vol.2012 (2012), p.1-6

2012

Volltextzugriff (PDF)

Modelling of a lined tyre for predicting cavity noise mitigation

Applied acoustics, 2019-12, Vol.155, p.391-400

2019

Volltextzugriff (PDF)

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Biochemical pharmacology, 2019-06, Vol.164, p.94-105

2019

Volltextzugriff (PDF)

Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2011-02, Vol.96 (2), p.E288-E296

2011

Volltextzugriff (PDF)

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E572-E581

2014

Volltextzugriff (PDF)

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients

Cancer, 2014-12, Vol.120 (24), p.3923-3931

2014

Volltextzugriff (PDF)

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6547-6552

2016

Volltextzugriff (PDF)

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Oncology reports, 2018-05, Vol.39 (5), p.2306-2314

2018

Volltextzugriff (PDF)

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Investigational new drugs, 2016-12, Vol.34 (6), p.760-770

2016

Volltextzugriff (PDF)

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Oncotarget, 2015-10, Vol.6 (30), p.28743-28754

2015

Volltextzugriff (PDF)

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients

Investigational new drugs, 2018-08, Vol.36 (4), p.709-714

2018

Volltextzugriff (PDF)

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E528-E536

2012

Volltextzugriff (PDF)

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

Pharmacogenomics, 2016, Vol.17 (1), p.35-9

2016

Volltextzugriff (PDF)

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Molecular and cellular endocrinology, 2014-08, Vol.393 (1-2), p.56-64

2014

Volltextzugriff (PDF)

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

Journal of medicinal chemistry, 2014-02, Vol.57 (4), p.1225-1235

2014

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieActa Diabetologica Latina

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Dating the late Miocene marine sediments around the southern middle Durance valley (Provence, SE France): new evidences for a Tortonian age

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

Modelling of a lined tyre for predicting cavity noise mitigation

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

Aktive Filter

Suchergebnisse filtern